Project Number 3R43AG062058-01S1 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Development of CDK5-p25 modulator to treat Alzheimer's Disease and Frontotemporal Dementia Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator WERNER, JOHN KENT Principal Investigator First Name JOHN KENT Principal Investigator Last Name WERNER Awardee Organization COGENTIS THERAPEUTICS, INC. Awardee State Maryland Contact PI Country United States Project Detail Funding Opportunity Announcement PA-18-591: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional) FY Overall Cost $236,325 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
